Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.45 USD | +1.40% | +2.86% | -2.04% |
Mar. 13 | Transcript : Spero Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 | |
Mar. 13 | Spero Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Evolution of the average Target Price on Spero Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Spero Therapeutics, Inc.
HC Wainwright | |
Evercore ISI | |
Berenberg Bank | |
Cantor Fitzgerald | |
Cowen | |
Oppenheimer |
EPS Revisions
- Stock Market
- Equities
- SPRO Stock
- Consensus Spero Therapeutics, Inc.